共 50 条
- [21] Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint InhibitorsJAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (10) : 918 - 926Hobday, Sara B.Brody, Robert M.Kriegsman, BarryBasu, DevrajNewman, JasonCohen, Roger B.Lukens, J. NicholasSingh, AditiD'Avella, Christopher A.Sun, Lova
- [22] Clinical activity of anti -programmed death-1 (PD-1) agents in acral and mucosal melanoma.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Munhoz, Rodrigo RamellaShoushtari, Alexander NoorKuk, DeborahOtt, Patrick AlexanderJohnson, Douglas BucknerTsai, Katy K.Rapisuwon, SutheeEroglu, ZeynepSullivan, Ryan J.Luke, Jason JohnGangadhar, Tara C.Salama, April K.Clark, VarinaBurias, ClarePuzanov, IgorAtkins, Michael B.Algazi, Alain PatrickRibas, AntoniWolchok, Jedd D.Postow, Michael Andrew
- [23] The Role of Programmed Cell Death-1 (PD-1) and Its Ligands in Pediatric CancerPEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 190 - 197van Dam, Laura S.de Zwart, Verena M.Meyer-Wentrup, Friederike A. G.
- [24] Programmed Death-1 (PD-1) Receptor/PD-1 Ligand (PD-L1) Expression in Fumarate Hydratase-Deficient Renal Cell CarcinomaLABORATORY INVESTIGATION, 2017, 97 : 211A - 211AAlaghehbandan, RezaStehlik, JanTrpkov, KirilMagi-Galluzzi, CristinaFoix, Maria PaneBerney, DanielSibony, MathildeSuster, SaulAgaimy, AbbasMontiel, Delia PerezPivovarcikova, KristynaMichalova, KvetoslavaDaum, OndrejOndic, OndrejRotterova, PavlaMichal, MichalHes, Ondrej
- [25] Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neckJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (03) : 527 - 533Maria Garcia-Pedrero, JuanaMartinez-Camblor, PabloDiaz-Coto, SusanaMunguia-Calzada, PabloVallina-Alvarez, AitanaVazquez-Lopez, FranciscoPablo Rodrigo, JuanSantos-Juanes, Jorge
- [26] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung CarcinomaMODERN PATHOLOGY, 2017, 30 : 475A - 475ADriver, BrandonMiller, Ross A.Deavers, MichaelTacha, DavidBernicker, EricCagle, Philip T.
- [27] Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinomaANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 29 : 17 - 22Alaghehbandan, RezaStehlik, JanTrpkov, KirilMagi-Galluzzi, CristinaMundo, Enric CondomFoix, Maria PaneBerney, DanielSibony, MathildeSuster, SaulAgaimy, AbbasMontiel, Delia PerezPivovarcikova, KristynaMichalova, KvetoslavaDaum, OndrejOndic, OndrejRotterova, PavlaDusek, MartinHora, MilanMichal, MichalHes, Ondrej
- [28] Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (08): : 1088 - 1095Malm, Ian-JamesBruno, Tullia C.Fu, JuanZeng, QiTaube, Janis M.Westra, WilliamPardoll, DrewDrake, Charles G.Kim, Young J.
- [29] Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimicsHISTOPATHOLOGY, 2020, 77 (02) : 240 - 249Cassol, Clarissa A.Owen, DwightKendra, KariBraga, Juarez R.Frankel, Wendy L.Arnold, Christina A.
- [30] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung CarcinomaLABORATORY INVESTIGATION, 2017, 97 : 475A - 475ADriver, BrandonMiller, Ross A.Deavers, MichaelTacha, DavidBernicker, EricCagle, Philip T.